Trial intelligence / Profile preview

Effect of NSAIDs in Helicobacter pylori treatment

IRCT201204059256N2Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of meloxicam in Helicobacter pylori infection, sponsored by Isfahan University of Medical Sciences. Started Apr 2010; status: completed.

02

Drugs

meloxicam
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on IRCT201204059256N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201204059256N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call